Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > RE :TFSA

<< Previous

Bullboard Posts

Next >>

Comment by stephanedodieron Jan 05, 2022 4:37pm

131 Views

Post# 34286927

RE:RE:RE:RE:RE :TFSA

FYI : My strategy was the following.

I did transfer $6000 in TH value (around 1600 shares) from my investment account to my TFSA/CELI account, so I can start the year with a lost to apply against any profit I can easily make on any other stock in my portfolio without selling any TH at all.

I am not saying that it's the think to do but just share idea with you.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing